Botulinum Toxin Treatment in Clinical Medicine

Lieferzeit: Lieferbar innerhalb 14 Tagen

171,19 

A Disease-Oriented Approach

ISBN: 3319858106
ISBN 13: 9783319858104
Herausgeber: Bahman Jabbari
Verlag: Springer Verlag GmbH
Umfang: x, 309 S., 10 s/w Illustr., 36 farbige Illustr., 309 p. 46 illus., 36 illus. in color.
Erscheinungsdatum: 18.08.2018
Auflage: 1/2018
Produktform: Kartoniert
Einband: KT

This book provides BoNT treatment menus for symptom-oriented therapy in 14 different disease categories. Each chapter starts with a brief description of the disease and its current treatment followed by an evidenced-based review of BoNT efficacy for the symptom(s) of that disease. The level of efficacy is provided based upon the published assertions of the Therapeutic Subcommittee of the American Academy of Neurology. Each chapter includes case histories from the editor’s vast experience of over 25 years with BoNT therapy and descriptions of injection techniques enhanced by illustrative figures. Botulinum Toxin Treatment in Clinical Medicine provides an additional introductory chapter that discusses molecular structure, mechanism of action, toxin serotypes, immunogenicity and safety issues. Meanwhile, a concluding chapter provides information on potential future application of these toxins for treating symptoms of other specific diseases.

Artikelnummer: 6778297 Kategorie:

Beschreibung

This book provides BoNT treatment menus for symptom-oriented therapy in 14 different disease categories.Each chapter starts with a brief description of the disease and its current treatment followed by an evidenced-based upon the published assertions of the Therapeutic Subcommittee of the American Academy of Neurology. Each chapter includes case histories from editor's vast experience of over 25 years with BoNT therapy and description of injection techniques enhanced by illustrative figures. Botulinum Toxin Treatment in Clinical Medicine includes an additional introductory chapter that discusses molecular structure, mechanism of action, toxin serotypes, immunogenicity and safety issues. Meanwhile, a concluding chapter provides information on potential future application of these toxins' for treating symptoms of other specific diseases.

Autorenporträt

The editor is Professor Emeritus of Neurology at the Yale University School of Medicine. He was director of the botulinum toxin treatment program at Yale from January 2005 to September 2015. His experience with botulinum toxin therapy of a large volume of patients extends over 25 years, and he has written extensively on the role of botulinum toxin therapy in clinical medicine.

Das könnte Ihnen auch gefallen …